ArticleJournal of cardiothoracic surgery2026
From metabolic to pathologic complete response: case report of Neoadjuvant Lorlatinib in Stage IIIB ALK-positive NSCLC combined with uniportal VATS.
Ruifeng Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.